Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment.
Minowa T, Murata K, Mizue Y, Murai A, Nakatsugawa M, Sasaki K, Tokita S, Kubo T, Kanaseki T, Tsukahara T, Handa T, Sato S, Horimoto K, Kato J, Hida T, Hirohashi Y, Uhara H, Torigoe T. Minowa T, et al. Among authors: kubo t. Sci Transl Med. 2024 Dec 4;16(776):eadk8832. doi: 10.1126/scitranslmed.adk8832. Epub 2024 Dec 4. Sci Transl Med. 2024. PMID: 39630887
Tumor-infiltrating CD8+ T cells recognize a heterogeneously expressed functional neoantigen in clear cell renal cell carcinoma.
Matsuki M, Hirohashi Y, Nakatsugawa M, Murai A, Kubo T, Hashimoto S, Tokita S, Murata K, Kanaseki T, Tsukahara T, Nishida S, Tanaka T, Kitamura H, Masumori N, Torigoe T. Matsuki M, et al. Among authors: kubo t. Cancer Immunol Immunother. 2022 Apr;71(4):905-918. doi: 10.1007/s00262-021-03048-6. Epub 2021 Sep 7. Cancer Immunol Immunother. 2022. PMID: 34491407 Free PMC article.
Fusion with type 2 macrophages induces melanoma cell heterogeneity that potentiates immunological escape from cytotoxic T lymphocytes.
Minowa T, Hirohashi Y, Murata K, Sasaki K, Handa T, Nakatsugawa M, Mizue Y, Murai A, Kubo T, Kanaseki T, Tsukahara T, Iwabuchi S, Hashimoto S, Ishida-Yamamoto A, Uhara H, Torigoe T. Minowa T, et al. Among authors: kubo t. J Pathol. 2023 Jul;260(3):304-316. doi: 10.1002/path.6083. Epub 2023 May 3. J Pathol. 2023. PMID: 37138382
The future of immunotherapy for sarcoma.
Tsukahara T, Emori M, Murata K, Mizushima E, Shibayama Y, Kubo T, Kanaseki T, Hirohashi Y, Yamashita T, Sato N, Torigoe T. Tsukahara T, et al. Among authors: kubo t. Expert Opin Biol Ther. 2016 Aug;16(8):1049-57. doi: 10.1080/14712598.2016.1188075. Epub 2016 May 27. Expert Opin Biol Ther. 2016. PMID: 27158940 Review.
Peptide vaccination therapy: Towards the next generation.
Tsukahara T, Hirohashi Y, Kanaseki T, Nakatsugawa M, Kubo T, Sato N, Torigoe T. Tsukahara T, et al. Among authors: kubo t. Pathol Int. 2016 Oct;66(10):547-553. doi: 10.1111/pin.12438. Epub 2016 Jul 19. Pathol Int. 2016. PMID: 27435148 Review.
[Dendritic cell and cancer immune checkpoint].
Kubo T, Hirohashi Y, Torigoe T. Kubo T, et al. Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(5):468-472. doi: 10.2177/jsci.39.468. Nihon Rinsho Meneki Gakkai Kaishi. 2016. PMID: 27795504 Free article. Review. Japanese.
4,393 results